Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Shares Outstanding (2016 - 2025)

Palisade Bio (PALI) has disclosed Shares Outstanding for 16 consecutive years, with $200000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding fell 83.31% to $200000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $200000.0, a 83.31% decrease, with the full-year FY2024 number at $2.8 million, up 1284.32% from a year prior.
  • Shares Outstanding was $200000.0 for Q3 2025 at Palisade Bio, down from $4.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $12.9 million in Q3 2021 to a low of $196287.0 in Q4 2022.
  • A 5-year average of $1.6 million and a median of $200000.0 in 2021 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: plummeted 98.29% in 2022, then skyrocketed 1284.32% in 2024.
  • Palisade Bio's Shares Outstanding stood at $11.7 million in 2021, then tumbled by 98.29% to $200000.0 in 2022, then changed by 0.0% to $200000.0 in 2023, then surged by 1284.32% to $2.8 million in 2024, then crashed by 92.78% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Shares Outstanding are $200000.0 (Q3 2025), $200000.0 (Q2 2025), and $4.4 million (Q1 2025).